Erratum: Author correction to "The upregulated intestinal folate transporters direct the uptake of ligand-modified nanoparticles for enhanced oral insulin delivery" [Acta Pharm Sin B 12 (2022) 1460-1472].
Saved in:
| Title: | Erratum: Author correction to "The upregulated intestinal folate transporters direct the uptake of ligand-modified nanoparticles for enhanced oral insulin delivery" [Acta Pharm Sin B 12 (2022) 1460-1472]. |
|---|---|
| Authors: | Li J; School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China., Zhang Y; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.; University of Chinese Academy of Sciences, Beijing 100049, China., Yu M; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China., Wang A; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.; University of Chinese Academy of Sciences, Beijing 100049, China., Qiu Y; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.; University of Chinese Academy of Sciences, Beijing 100049, China., Fan W; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China., Hovgaard L; Oral Formulation Development, Novo Nordisk A/S, Maalov 2760, Denmark., Yang M; Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen 2100, Denmark., Li Y; School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China., Wang R; School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China., Li X; University of Texas at Dallas, Richardson, TX 75080, USA., Gan Y; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.; University of Chinese Academy of Sciences, Beijing 100049, China.; NMPA Key Laboratory for Quality Research and Evaluation of Pharmaceutical Excipients, National Institutes for Food and Drug Control, Beijing 100050, China. |
| Source: | Acta pharmaceutica Sinica. B [Acta Pharm Sin B] 2025 Jun; Vol. 15 (6), pp. 3353. Date of Electronic Publication: 2025 Apr 16. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101600560 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2211-3835 (Print) Linking ISSN: 22113835 NLM ISO Abbreviation: Acta Pharm Sin B Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40654346 AccessLevel: 2 PubTypeId: unknown PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Erratum: Author correction to "The upregulated intestinal folate transporters direct the uptake of ligand-modified nanoparticles for enhanced oral insulin delivery" [Acta Pharm Sin B 12 (2022) 1460-1472]. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Li+J%22">Li J</searchLink>; School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.<br /><searchLink fieldCode="AU" term="%22Zhang+Y%22">Zhang Y</searchLink>; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.; University of Chinese Academy of Sciences, Beijing 100049, China.<br /><searchLink fieldCode="AU" term="%22Yu+M%22">Yu M</searchLink>; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.<br /><searchLink fieldCode="AU" term="%22Wang+A%22">Wang A</searchLink>; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.; University of Chinese Academy of Sciences, Beijing 100049, China.<br /><searchLink fieldCode="AU" term="%22Qiu+Y%22">Qiu Y</searchLink>; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.; University of Chinese Academy of Sciences, Beijing 100049, China.<br /><searchLink fieldCode="AU" term="%22Fan+W%22">Fan W</searchLink>; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.<br /><searchLink fieldCode="AU" term="%22Hovgaard+L%22">Hovgaard L</searchLink>; Oral Formulation Development, Novo Nordisk A/S, Maalov 2760, Denmark.<br /><searchLink fieldCode="AU" term="%22Yang+M%22">Yang M</searchLink>; Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen 2100, Denmark.<br /><searchLink fieldCode="AU" term="%22Li+Y%22">Li Y</searchLink>; School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.<br /><searchLink fieldCode="AU" term="%22Wang+R%22">Wang R</searchLink>; School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.<br /><searchLink fieldCode="AU" term="%22Li+X%22">Li X</searchLink>; University of Texas at Dallas, Richardson, TX 75080, USA.<br /><searchLink fieldCode="AU" term="%22Gan+Y%22">Gan Y</searchLink>; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.; University of Chinese Academy of Sciences, Beijing 100049, China.; NMPA Key Laboratory for Quality Research and Evaluation of Pharmaceutical Excipients, National Institutes for Food and Drug Control, Beijing 100050, China. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101600560%22">Acta pharmaceutica Sinica. B</searchLink> [Acta Pharm Sin B] 2025 Jun; Vol. 15 (6), pp. 3353. <i>Date of Electronic Publication: </i>2025 Apr 16. – Name: TypePub Label: Publication Type Group: TypPub Data: Published Erratum – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>101600560 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2211-3835 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222113835%22">22113835 </searchLink><i>NLM ISO Abbreviation: </i>Acta Pharm Sin B <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40654346 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.apsb.2025.04.015 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 3353 Titles: – TitleFull: Erratum: Author correction to "The upregulated intestinal folate transporters direct the uptake of ligand-modified nanoparticles for enhanced oral insulin delivery" [Acta Pharm Sin B 12 (2022) 1460-1472]. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Li J – PersonEntity: Name: NameFull: Zhang Y – PersonEntity: Name: NameFull: Yu M – PersonEntity: Name: NameFull: Wang A – PersonEntity: Name: NameFull: Qiu Y – PersonEntity: Name: NameFull: Fan W – PersonEntity: Name: NameFull: Hovgaard L – PersonEntity: Name: NameFull: Yang M – PersonEntity: Name: NameFull: Li Y – PersonEntity: Name: NameFull: Wang R – PersonEntity: Name: NameFull: Li X – PersonEntity: Name: NameFull: Gan Y IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2025 Jun Type: published Y: 2025 Identifiers: – Type: issn-print Value: 2211-3835 Numbering: – Type: volume Value: 15 – Type: issue Value: 6 Titles: – TitleFull: Acta pharmaceutica Sinica. B Type: main |
| ResultId | 1 |
